Open AccessS0652 Real World Exposure-Response Relationship of Vedolizumab in Inflammatory Bowel Disease: A Pooled Multicenter Observational Cohort Analysis of Clinical and Modeled Pharmacological Data
Author(s) -
Niels Vande Casteele,
William J. Sandborn,
Brian G. Feagan,
Séverine Vermeire,
Parambir S. Dulai,
Julián Panés,
Andrés Yarur,
Xavier Roblin,
Shomron BenHorin,
Iris Dotan,
Mark T. Osterman,
Dirk Lindner,
Christian Agboton,
Maria Rosario,
Teresa Osborn
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000704656.65634.c9
Subject(s) - vedolizumab , medicine , inflammatory bowel disease , ulcerative colitis , therapeutic drug monitoring , dosing , population , gastroenterology , disease , pharmacokinetics , environmental health